• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity, Equity & Inclusion
    • Pro Bono
    • Client Service Values
    • Alumni
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Blockchain, Smart Contracts & Digital Currencies
Business Litigation
Cannabis
Coronavirus Resource Center
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Food & Beverage
Government Affairs
Government Contracts & Global Trade
Government Investigations & White Collar Defense
Healthcare
Hospitality
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
Insights Publication Magazine Pages
Main image for USPTO Issues Written Description Guidance on Antibody Claims in View of Amgen v. Sanofi Case
Publications|Alert

USPTO Issues Written Description Guidance on Antibody Claims in View of Amgen v. Sanofi Case

Intellectual Property Alert

3.19.2018

In Amgen Inc. v. Sanofi, Opinion No. 17-1480 (Fed. Cir., Oct. 5, 2017), the Federal Circuit rejected the “newly characterized antigen” test as a means of satisfying the written description requirement for a claim to antibodies.  The patents-in-suit are directed to antibodies that target PCSK9. These patents do not claim any particular antibody by amino acid sequence, but instead claim the entire genus of antibodies that bind to at least one of 15 specified amino acid residues of PCSK9 and block PCSK9 from binding to low-density lipoprotein receptors. During trial, the district court instructed the jury that the written description requirement for a claim to antibodies may be satisfied “by the disclosure of a newly characterized antigen by its structure, formula, chemical name, or physical properties” if the production of antibodies against such an antigen was conventional or routine. The jury found the claims to be valid.   

The Federal Circuit (a panel made up of Chief Judge Prost, Judge Taranto and Judge Hughes) disagreed and, in what appears to be a clear departure from previous holdings, rejected the Noelle v. Lederman test (i.e., that characterizing a new antigen is sufficient to satisfy the statute for claims encompassing a broad genus of antibodies that could bind to the new antigen).

The USPTO issued guidance on antibody claims in view of the Amgen decision.  In the guidance, the USPTO indicates that “[i]n view of the Amgen decision, adequate written description of a newly characterized antigen alone should not be considered adequate written description of a claimed antibody to that newly characterized antigen, even when preparation of such an antibody is routine and conventional.” The Memorandum further states that “[w]ritten description training materials containing examples that reflect developments in the law regarding 35 U.S.C. §§ 101 and 112 are being prepared.” Stay tuned for more developments in this area.

sidebar

pdfemail

Related People

Media item: Maria Laccotripe Zacharakis, PhD
Maria Laccotripe Zacharakis, PhD

Partner

Media item: Marcie Beth Clarke, PhD
Marcie Beth Clarke, PhD

Partner

Related Services

Intellectual Property
Subscribe to our Insights
McCarter & English, LLP
Copyright © 2023 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel